Annual EBITDA
-$192.36M$107.70M-127.22%
Summary
- Current Value
- As of today, MLYS annual EBITDA is -$192.36M, down -127.22% on
- Historical Performance
- MLYS annual EBITDA is down -892.52% over the past 3 years, and down -5709.73% over the past 5 years
- All-Time High Comparison
- MLYS annual EBITDA is currently -5709.73% below its historical high of -$3.31M set on
- 3-Year Low Comparison
- MLYS annual EBITDA is at its 3-year low
- Sector Comparison
- MLYS annual EBITDA is higher than 8.14% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | -$192.36M | -127.2% | -892.5% | -5709.7% | -5709.7% | |
| Quarterly EBITDA | -$41.12M | +31.6% | -453.9% | -480.5% | -480.5% | |
| TTM EBITDA | -$184.03M | -9.3% | -544.5% | -2498.2% | -2498.2% | |
| Price | $33.22 | +196.6% | – | – | – | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $0.00 | 0.0% | 0.0% | 0.0% | 0.0% | |
| Annual EPS | -$3.66 | -84.4% | -915.9% | -5247.7% | -5247.7% | |
| Annual EBIT | -$192.40M | -127.3% | -892.7% | -5711.0% | -5711.0% | |
| Annual Net Income | -$177.81M | -147.3% | -816.2% | -5090.0% | -5090.0% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | -$31.48M | N/A | -511.1% |
| 5Y | -$3.31M | N/A | -5709.7% |
| All | -$3.31M | -5709.7% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$192.36M | at low | |
| 5Y | -$192.36M | at low | |
| All | -$192.36M | at low |
EBITDA History
| Year | Value | Change |
|---|---|---|
| -$192.36M | -127.2% | |
| -$84.66M | -168.9% | |
| -$31.48M | -62.4% |
| Year | Value | Change |
|---|---|---|
| -$19.38M | -485.4% | |
| -$3.31M | - |
FAQ
What is the current annual EBITDA of MLYS?
As of today, MLYS annual EBITDA is -$192.36M
What is 1-year change in MLYS annual EBITDA?
MLYS annual EBITDA is down -127.22% year-over-year
What is 3-year change in MLYS annual EBITDA?
MLYS annual EBITDA is down -892.52% over the past 3 years
How far is MLYS annual EBITDA from its all-time high?
MLYS annual EBITDA is currently -5709.73% below its historical high of -$3.31M set on December 1, 2020
How does MLYS annual EBITDA rank versus sector peers?
MLYS annual EBITDA is higher than 8.14% of companies in Healthcare sector
When is MLYS next annual earnings release?
The next annual earnings release for MLYS is on
Quarterly EBITDA
-$41.12M$5.61M+12.01%
Summary
- Current Value
- As of today, MLYS quarterly EBITDA is -$41.12M, up +12.01% on
- Historical Performance
- MLYS quarterly EBITDA is up +31.58% year-over-year, and down -453.90% over the past 3 years
- All-Time High Comparison
- MLYS quarterly EBITDA is currently -534.60% below its historical high of -$6.48M set on
- 3-Year Low Comparison
- MLYS quarterly EBITDA is +31.58% above its 3-year low of -$60.10M reached on
- Sector Comparison
- MLYS quarterly EBITDA is higher than 10.03% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | -$41.12M | +12.0% | +31.6% | -453.9% | -480.5% | |
| Annual EBITDA | -$192.36M | – | -127.2% | -892.5% | -5709.7% | |
| TTM EBITDA | -$184.03M | +9.3% | -9.3% | -544.5% | -2498.2% | |
| Price | $33.22 | -15.7% | +196.6% | – | – | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $0.00 | 0.0% | 0.0% | 0.0% | 0.0% | |
| Quarterly EPS | -$0.52 | +20.9% | +53.7% | -220.0% | -334.2% | |
| Quarterly EBIT | -$41.13M | +12.0% | +31.6% | -454.1% | -480.7% | |
| Quarterly Net Income | -$36.93M | +14.7% | +34.5% | -453.0% | -421.4% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$41.12M | at high | |
| 3Y | -$10.01M | N/A | -310.8% |
| 5Y | -$6.48M | -534.6% | |
| All | -$6.48M | -534.6% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$51.75M | N/A | +20.6% |
| 3Y | -$60.10M | +31.6% | |
| 5Y | -$60.10M | +31.6% | |
| All | -$60.10M | +31.6% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of MLYS?
As of today, MLYS quarterly EBITDA is -$41.12M
What is MLYS quarterly EBITDA most recent change?
MLYS quarterly EBITDA was up +12.01% on September 30, 2025
What is 1-year change in MLYS quarterly EBITDA?
MLYS quarterly EBITDA is up +31.58% year-over-year
How far is MLYS quarterly EBITDA from its all-time high?
MLYS quarterly EBITDA is currently -534.60% below its historical high of -$6.48M set on June 1, 2022
How does MLYS quarterly EBITDA rank versus sector peers?
MLYS quarterly EBITDA is higher than 10.03% of companies in Healthcare sector
When is MLYS next earnings release?
The next earnings release for MLYS is on
TTM EBITDA
-$184.03M$18.98M+9.35%
Summary
- Current Value
- As of today, MLYS TTM EBITDA is -$184.03M, up +9.35% on
- Historical Performance
- MLYS TTM EBITDA is down -9.33% year-over-year, and down -544.50% over the past 3 years
- All-Time High Comparison
- MLYS TTM EBITDA is currently -2498.19% below its historical high of -$7.08M set on
- 3-Year Low Comparison
- MLYS TTM EBITDA is +9.35% above its 3-year low of -$203.01M reached on
- Sector Comparison
- MLYS TTM EBITDA is higher than 8.04% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | -$184.03M | +9.3% | -9.3% | -544.5% | -2498.2% | |
| Annual EBITDA | -$192.36M | – | -127.2% | -892.5% | -5709.7% | |
| Quarterly EBITDA | -$41.12M | +12.0% | +31.6% | -453.9% | -480.5% | |
| Price | $33.22 | -15.7% | +196.6% | – | – | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $0.00 | 0.0% | 0.0% | 0.0% | 0.0% | |
| TTM EPS | -$2.96 | +17.0% | +9.6% | -371.1% | -2354.8% | |
| TTM EBIT | -$184.09M | +9.3% | -9.3% | -544.7% | -2499.1% | |
| TTM Net Income | -$171.36M | +10.2% | -11.8% | -516.2% | -2319.4% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$184.03M | at high | |
| 3Y | -$31.48M | N/A | -484.6% |
| 5Y | -$7.08M | -2498.2% | |
| All | -$7.08M | -2498.2% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$203.01M | +9.3% | |
| 3Y | -$203.01M | +9.3% | |
| 5Y | -$203.01M | +9.3% | |
| All | -$203.01M | +9.3% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of MLYS?
As of today, MLYS TTM EBITDA is -$184.03M
What is MLYS TTM EBITDA most recent change?
MLYS TTM EBITDA was up +9.35% on September 30, 2025
What is 1-year change in MLYS TTM EBITDA?
MLYS TTM EBITDA is down -9.33% year-over-year
How far is MLYS TTM EBITDA from its all-time high?
MLYS TTM EBITDA is currently -2498.19% below its historical high of -$7.08M set on December 1, 2021
How does MLYS TTM EBITDA rank versus sector peers?
MLYS TTM EBITDA is higher than 8.04% of companies in Healthcare sector
When is MLYS next earnings release?
The next earnings release for MLYS is on
EBITDA Formula
EBITDA = + + +
Data Sources & References
- MLYS Official Website mineralystx.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1933414/000193341425000142/0001933414-25-000142-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1933414/000193341425000009/0001933414-25-000009-index.htm
- MLYS Profile on Yahoo Finance finance.yahoo.com/quote/MLYS
- MLYS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/mlys